Kral M - Search Results

1

Long-term low-dose glucocorticoid therapy in hyperandrogenized women: utility and effects on bone mineral content and hypothalamic-pituitary-adrenocortical function.

Contreras LN, Rizzo L, Gómez RM, Zanchetta JR, Rossi MA, Kral M, Masini AM, Bruno OD. Contreras LN, et al. Among authors: kral m. Horm Res. 1991;35(3-4):142-5. doi: 10.1159/000181890. Horm Res. 1991. PMID: 1839628 Clinical Trial.

2

Low-dose glucocorticoids in hyperandrogenism.

Rizzo L, Dobrovsky V, Danilowicz K, Kral M, Cross G, Serra HA, Bruno OD. Rizzo L, et al. Among authors: kral m. Medicina (B Aires). 2007;67(3):247-52. Medicina (B Aires). 2007. PMID: 17628912 Clinical Trial.

3

Glucocorticoids: their role on gonadal function and LH secretion.

Contreras LN, Masini AM, Danna MM, Kral M, Bruno OD, Rossi MA, Andrada JA. Contreras LN, et al. Among authors: kral m. Minerva Endocrinol. 1996 Jun;21(2):43-6. Minerva Endocrinol. 1996. PMID: 8968148

4

Nocturnal high-dose dexamethasone suppression test in the aetiological diagnosis of Cushing's syndrome.

Bruno OD, Rossi MA, Contreras LN, Gómez RM, Galparsoro G, Cazado E, Kral M, Leber B, Arias D. Bruno OD, et al. Among authors: kral m. Acta Endocrinol (Copenh). 1985 Jun;109(2):158-62. doi: 10.1530/acta.0.1090158. Acta Endocrinol (Copenh). 1985. PMID: 2990131

5

Sex hormone binding globulin decrease as a potential pathogenetic factor for hirsutism in adolescent girls.

Cross G, Danilowicz K, Kral M, Caufriez A, Copinschi G, Bruno OD. Cross G, et al. Among authors: kral m. Medicina (B Aires). 2008;68(2):120-4. Medicina (B Aires). 2008. PMID: 18499959 Clinical Trial.

6

The Artisse intrasaccular device for the treatment of cerebral aneurysms: initial experience from three Austrian neurovascular centers.

Hecker C, Janu A, Pfaff JAR, Pikija S, Sonnberger M, Pangratz-Daller C, Kral M, Lunzer M, Griessenauer CJ, Killer-Oberpfalzer M. Hecker C, et al. Among authors: kral m. J Neurointerv Surg. 2025 Jan 3:jnis-2024-022486. doi: 10.1136/jnis-2024-022486. Online ahead of print. J Neurointerv Surg. 2025. PMID: 39753342

7

The evaluation of DNA-linked inhibitor antibody and AlphaScreen assays for high-throughput screening of compounds targeting the cap-binding domain in influenza a polymerase.

Čermáková K, Gregor J, Kráľ M, Karlukova E, Navrátil V, Reiberger R, Albiñana CB, Bechynský V, Majer P, Konvalinka J, Machara A, Kožíšek M. Čermáková K, et al. Among authors: kral m. Eur J Pharm Sci. 2025 Feb 1;205:106990. doi: 10.1016/j.ejps.2024.106990. Epub 2024 Dec 12. Eur J Pharm Sci. 2025. PMID: 39674552 Free article.

8

(Multi-) omics studies of ILC2s in inflammation and metabolic diseases.

Kral M, van der Vorst EPC, Weber C, Döring Y. Kral M, et al. Front Cell Dev Biol. 2024 Oct 28;12:1473616. doi: 10.3389/fcell.2024.1473616. eCollection 2024. Front Cell Dev Biol. 2024. PMID: 39529633 Free PMC article. Review.

9

Early intermittent cholesterol exposure accelerates atherosclerosis: an oscillating amplifier calling for preemptive control.

Kral M, Döring Y, Weber C. Kral M, et al. Signal Transduct Target Ther. 2024 Nov 7;9(1):313. doi: 10.1038/s41392-024-02032-7. Signal Transduct Target Ther. 2024. PMID: 39511160 Free PMC article. No abstract available.

10

3'-Dehydroxypurpurogallin-4-Carboxamides as Influenza A Endonuclease Inhibitors: Synthesis, Structure-Activity Relationship Analysis, and Structural Characterization of Protein Complex.

Kráľ M, Kotačka T, Reiberger R, Panýrková G, Radilová K, Osifová Z, Flieger M, Konvalinka J, Majer P, Kožíšek M, Machara A. Kráľ M, et al. ChemMedChem. 2024 Oct 14:e202400577. doi: 10.1002/cmdc.202400577. Online ahead of print. ChemMedChem. 2024. PMID: 39400442

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

195 results

Search Page

Filters